MAY 06, 2021 6:30 AM PDT

COVID Vaccines Don't Protect Everyone

WRITTEN BY: Tara Fernandez

New research has revealed that COVID-19 vaccines may not work as effectively in those whose immune systems have been negatively impacted by underlying medical conditions or the drugs used to treat those conditions.

These findings are not entirely surprising. For instance, previous investigations in immunocompromised people had pointed towards the possibility that vaccines may not perform optimally in these populations. In the VACANCE study of 2012, for example, less than half of the participants (who were cancer patients undergoing chemotherapy) produced antibodies to influenza after receiving the vaccine.

Based on these and other findings, scientists were seeking answers on whether similarly low immune responses would be observed when these vulnerable groups got the COVID-19 vaccination. So far, evidence is supporting this theory. A Johns Hopkins University study in which patients who were the recipients of organ transplants showed poor antibody responses to the Pfizer-BioNTech and Moderna vaccines—a mere 17% of the participants showed detectable levels of antibodies against SARS-CoV-2.

Similar results have also been reported in those with autoimmune conditions. Data published on the preprint server medRxiv indicated that on average, the participants who were on medications to manage chronic inflammatory diseases produced about one-third as many antibodies as healthy individuals who receive the COVID vaccine.

“CID patients treated with immunosuppressive therapies exhibit impaired SARS-CoV-2 vaccine-induced immunity, with glucocorticoids and B cell depletion therapy more severely impeding optimal responses,” wrote the authors.

For now, ways to improve immune responses for these at-risk groups are still being explored. Additional doses of the standard COVID vaccinations, mixing vaccines, or the use of monoclonal antibodies, have been proposed as possible solutions for protecting these patients.

 


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 14, 2021
Immunology
Extinguishing Fires in the Brains of MS Patients
SEP 14, 2021
Extinguishing Fires in the Brains of MS Patients
  A closer look at the brains of patients with aggressive, debilitating forms of multiple sclerosis (MS) reveals so ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
NOV 04, 2021
Immunology
Trial Flop: Experimental Asthma Treatment Makes Symptoms Worse
NOV 04, 2021
Trial Flop: Experimental Asthma Treatment Makes Symptoms Worse
One causes red, scaly patches on the skin, and the other triggers breathing difficulties, but there are some common thre ...
NOV 21, 2021
Microbiology
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
NOV 21, 2021
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
Zoonosis is a serious health concern, as the COVID-19 pandemic has shown. Viruses that infect one species can acquire ge ...
DEC 02, 2021
Microbiology
Antibodies Seem to Keep Gut Fungi in Check, Except in Crohn's Patients
DEC 02, 2021
Antibodies Seem to Keep Gut Fungi in Check, Except in Crohn's Patients
The bacteria that live in the gut microbiome have gotten a lot of attention, and for good reason; gut bacteria have been ...
Loading Comments...